CAD 1.64
(0.61%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -228.71 Million CAD | -113.74% |
2022 | 1.66 Billion CAD | 253.8% |
2021 | -1.08 Billion CAD | -2543.96% |
2020 | 44.3 Million CAD | 102.65% |
2019 | -1.66 Billion CAD | -201.45% |
2018 | -553.64 Million CAD | -601.93% |
2017 | -78.87 Million CAD | -418.4% |
2016 | -15.21 Million CAD | -453.47% |
2015 | -2.74 Million CAD | 64.47% |
2014 | -7.73 Million CAD | -730.47% |
2013 | -931.65 Thousand CAD | -1342.01% |
2012 | -64.6 Thousand CAD | -202.01% |
2011 | -21.39 Thousand CAD | -9.26% |
2010 | -19.58 Thousand CAD | 27.26% |
2009 | -26.91 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -21.31 Million CAD | 36.94% |
2023 Q1 | -91.34 Million CAD | -144.44% |
2023 Q2 | -7 Million CAD | 92.33% |
2023 Q3 | -60.31 Million CAD | -760.8% |
2023 Q4 | -33.79 Million CAD | 43.97% |
2023 FY | -228.71 Million CAD | -113.74% |
2022 Q2 | -131.87 Million CAD | -108.15% |
2022 Q1 | 1.61 Billion CAD | 405.44% |
2022 Q3 | -153.76 Million CAD | -16.59% |
2022 Q4 | 205.55 Million CAD | 233.68% |
2022 FY | 1.66 Billion CAD | 253.8% |
2021 Q2 | -215.35 Million CAD | -14.73% |
2021 FY | -1.08 Billion CAD | -2543.96% |
2021 Q1 | -187.71 Million CAD | 19.51% |
2021 Q3 | -111.9 Million CAD | 48.04% |
2021 Q4 | -529.64 Million CAD | -373.3% |
2020 Q3 | -553.61 Million CAD | -94.75% |
2020 Q1 | -172.37 Million CAD | 84.45% |
2020 Q2 | -284.26 Million CAD | -64.91% |
2020 FY | 44.3 Million CAD | 102.65% |
2020 Q4 | -233.2 Million CAD | 57.88% |
2019 Q4 | -1.1 Billion CAD | -546.28% |
2019 Q1 | -123.1 Million CAD | 29.44% |
2019 Q2 | -265.83 Million CAD | -115.94% |
2019 Q3 | -171.52 Million CAD | 35.48% |
2019 FY | -1.66 Billion CAD | -201.45% |
2018 Q2 | -214.62 Million CAD | -598.98% |
2018 Q4 | -174.46 Million CAD | -10.95% |
2018 Q3 | -157.24 Million CAD | 26.74% |
2018 Q1 | -30.7 Million CAD | 39.83% |
2018 FY | -553.64 Million CAD | -601.93% |
2017 Q2 | -1.14 Million CAD | 72.95% |
2017 Q3 | -26.03 Million CAD | -2169.57% |
2017 FY | -78.87 Million CAD | -418.4% |
2017 Q1 | -4.24 Million CAD | 80.73% |
2017 Q4 | -51.03 Million CAD | -96.04% |
2016 FY | -15.21 Million CAD | -453.47% |
2016 Q4 | -21.99 Million CAD | -562.82% |
2016 Q3 | 4.75 Million CAD | 177.7% |
2016 Q2 | -6.11 Million CAD | -49.67% |
2016 Q1 | -4.08 Million CAD | 18.21% |
2015 FY | -2.74 Million CAD | 64.47% |
2015 Q3 | -2.7 Million CAD | -168.24% |
2015 Q4 | -4.99 Million CAD | -84.87% |
2015 Q2 | 3.96 Million CAD | 299.01% |
2015 Q1 | 992.67 Thousand CAD | 411.38% |
2014 Q4 | -318.8 Thousand CAD | 87.99% |
2014 FY | -7.73 Million CAD | -730.47% |
2014 Q1 | -1.02 Million CAD | 62.76% |
2014 Q3 | -2.65 Million CAD | -90.44% |
2014 Q2 | -1.39 Million CAD | -36.04% |
2013 Q4 | -2.75 Million CAD | -9656.76% |
2013 FY | -931.65 Thousand CAD | -1342.01% |
2013 Q1 | -37.75 Thousand CAD | -667.75% |
2013 Q2 | -7269.00 CAD | 80.75% |
2013 Q3 | -28.19 Thousand CAD | -287.92% |
2012 Q3 | -11.92 Thousand CAD | 42.93% |
2012 FY | -64.6 Thousand CAD | -202.01% |
2012 Q2 | -20.89 Thousand CAD | -753.59% |
2012 Q4 | -4918.00 CAD | 58.76% |
2012 Q1 | -2448.00 CAD | 67.59% |
2011 Q3 | -7799.00 CAD | -571.75% |
2011 Q1 | 870.00 CAD | 113.72% |
2011 Q2 | -1161.00 CAD | -233.45% |
2011 Q4 | -7554.00 CAD | 3.14% |
2011 FY | -21.39 Thousand CAD | -9.26% |
2010 Q1 | -138.00 CAD | 98.43% |
2010 Q4 | -6341.00 CAD | 46.07% |
2010 FY | -19.58 Thousand CAD | 27.26% |
2010 Q3 | -11.75 Thousand CAD | -305.45% |
2010 Q2 | -2900.00 CAD | -2001.45% |
2009 Q2 | - CAD | 0.0% |
2009 FY | -26.91 Thousand CAD | 0.0% |
2009 Q3 | -18 Thousand CAD | 0.0% |
2009 Q4 | -8777.00 CAD | 51.25% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aurora Cannabis Inc. | -46.45 Million CAD | -392.356% |
Avicanna Inc. | -7.93 Million CAD | -2783.067% |
Avant Brands Inc. | -1.45 Million CAD | -15662.509% |
Cardiol Therapeutics Inc. | -29.78 Million CAD | -667.87% |
Crescita Therapeutics Inc. | -1.95 Million CAD | -11592.945% |
Knight Therapeutics Inc. | -2.89 Million CAD | -7813.979% |
MediPharm Labs Corp. | -18.25 Million CAD | -1153.09% |
OrganiGram Holdings Inc. | -242.73 Million CAD | 5.778% |
Willow Biosciences Inc. | -13.18 Million CAD | -1635.048% |
Auxly Cannabis Group Inc. | -19 Million CAD | -1103.441% |